中文 | English
Return
Total: 31 , 1/4
Show Home Prev Next End page: GO
Author:( Peizhong SHANG)

1.Expression and correlation of survivin and CD44v6 protein in gastric carcinoma

Huaping GU ; Peizhong SHANG

Journal of Xi'an Jiaotong University(Medical Sciences) 1982;0(04):-

2.Expression and clinical significance of galetin-3 and EGFR proteins in esophageal squamous carcinoma

Huaping GU ; Peizhong SHANG

Journal of International Oncology 2011;38(8):630-632

3.Expression of COX-2 and survivin protein in elderly patients with gastric cancer and its metastasis and prognosis

Huaping GU ; Peizhong SHANG

Journal of International Oncology 2012;39(5):387-390

4.Expression of COX-2 and VEGF protein in human papillary thyroid carcinoma and their relationship with metastasis and prognosis

Huaping GU ; Peizhong SHANG

Journal of Endocrine Surgery 2012;06(4):225-227

5.Significance of S100A4 expression in benign and malignant thyroid tissue

Peizhong SHANG ; Runling NAN ; Huaping GU

Journal of Endocrine Surgery 2010;04(6):375-378

6.Diagnosis and treatment of occult indirect inguinal hernia (A report of 60 cases)

Peizhong SHANG ; Jingzhang LIU ; Yuqi LU

Chinese Journal of Minimally Invasive Surgery 2001;0(05):-

7.Significancy of expression of tumor suppressor gene PTEN and p16 protein in cholangiocarcinoma

Huaping GU ; Peizhong SHANG ; Cuiling ZHOU

Chinese Journal of General Surgery 1993;0(02):-

8.A study on the expression of sialyl Lewis X in colorectal carcinoma

Peizhong SHANG ; Huaping GU ; Yinchen SUN

Chinese Journal of General Surgery 2001;0(10):-

9.Expression of LeX ,Sialyl-LeX, LeA and Sialyl-LeA in Colorectal Carcinoma and Its Significance

Peizhong SHANG ; Huaping GU ; Yinchen SUN

Journal of Chinese Physician 2000;0(11):-

10.Correlation between expression of CD44V6,E-cadherin and biological behavior in breast cancer

Huaping GU ; Peizhong SHANG ; Yanru LIU ;

China Oncology 2001;0(03):-

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 31 , 1/4 Show Home Prev Next End page: GO